## EVALUATION

---

### 1. Research Question Clarity — **8/10**

The question is precise and directly answerable: estimate β₃ from a 2×2 factorial design and test whether it is nonzero. The causal claim (superadditivity vs. substitutability) is well-specified, and the paper correctly notes that β₃ has a structural interpretation tying back to a policy-relevant decision (bundle or choose). Minor deduction: the heterogeneity analysis by gender/SES is mentioned but not operationalized — no power discussion, no subgroup pre-specification.

---

### 2. Identification Strategy — **8/10**

**Identification Tier: Tier 1 (RCT)**

**Source of exogenous variation:** Random assignment to one of four cells (neither, voucher only, training only, both). Randomization is the cleanest possible source of variation. β₃ = E[Y|both] − E[Y|voucher] − E[Y|training] + E[Y|neither] is identified nonparametrically from cell means, requiring no auxiliary assumptions beyond SUTVA and no-spillover.

**Is it clearly stated? Plausible?** Yes and yes. The factorial structure is correctly described and the LPM interaction regression is the appropriate estimator. The joint balance F-test across cells is the right pre-analysis check.

**Identification threats:**
- SUTVA violation: if treatment arms share labor markets, general equilibrium effects contaminate all four cells
- Compliance: if takeup is imperfect, β₃ is a LATE for compliers in all four arms simultaneously — the "complier" definition becomes complex
- The design assumes orthogonality of the two treatments in assignment, which must be verified

**Pre-trends:** Not applicable (RCT, not DiD). Balance tests substitute.

Deduction from 10: The proposal does not address compliance (is `treatstat` treatment *assigned* or *received*?), which is the primary complication in translating this clean design into a clean estimate.

---

### 3. Data Feasibility — **4/10**

Several serious concerns:

**Power for interaction effects:** This is the critical omission. Detecting a treatment × treatment interaction requires approximately **4× the sample** needed to detect a main effect of the same size. The proposal contains zero power analysis. If the study was powered for main effects, it is almost certainly underpowered to detect plausible magnitudes of β₃. A null result for β₃ under this design is statistically uninformative.

**Date range:** The four observation dates span July 17–24, 2010 — a **one-week window**. This almost certainly reflects baseline data or an administrative enrollment snapshot, not post-treatment follow-up. Vocational training effects on employment manifest over months to years. If this is baseline data, the outcome variables are pre-treatment and the paper cannot be written as specified.

**Variable opacity:** Outcome variables `l, t, w, e` are undefined. Without knowing what they measure, whether they are binary or continuous, and their pre-treatment distributions, data feasibility cannot be confirmed.

**Missing:** sample size per cell, attrition rates by arm (more intensive arms typically have higher dropout), survey response rates.

---

### 4. Novelty & Contribution — **7/10**

The proposal correctly identifies a genuine gap. Most program evaluations test interventions in isolation. Clean factorial RCTs that identify interaction effects are rare in the labor/development literature. The closest related work (Banerjee et al. graduation programs; some Uganda/Kenya vocational training trials) does not cleanly decompose complementarity. A well-executed paper here has publication potential in a top field journal. Deduction: the contribution depends entirely on the sign and magnitude of β₃ — if substitutes, the contribution is still important, but the paper must be framed carefully to avoid being read as "bundling doesn't work."

---

### 5. Policy Relevance / Impact — **8/10**

High relevance. Governments and multilateral agencies routinely face the bundling question (World Bank ALMPs, IDB workforce programs, USAID youth employment). A credible β₃ estimate — either sign — has direct implications for program design and cost-benefit analysis. The gender/SES heterogeneity analysis, if executed, adds targeting relevance.

---

### 6. Threats to Validity

| # | Threat | Severity | Addressed? |
|---|--------|----------|------------|
| 1 | **Underpowered interaction test**: Sample likely sized for main effects; β₃ = 0 may reflect noise, not true null | HIGH | No |
| 2 | **Timing/follow-up**: Date range suggests baseline or very early data; training effects need longer horizon | HIGH | No |
| 3 | **Non-compliance / LATE complexity**: `treatstat` variable suggests treatment receipt ≠ assignment; four-arm LATE is complex | MEDIUM | Partially (treatstat listed but not analyzed) |
| 4 | **SUTVA / spillovers**: Local labor market GE effects contaminate all cells if participants compete for same jobs | MEDIUM | No |
| 5 | **Multiple outcomes / selective reporting**: Four undefined outcome variables with no pre-specified primary outcome | MEDIUM | No |

**Threats_addressed score:** 10 − (2 HIGH unaddressed × 2) = **6**

---

### 7. Missing Elements

- Power calculation specifically for the interaction term β₃
- Sample size and allocation across the four cells
- Definition of outcome variables `l`, `t`, `w`, `e`
- Clarification of whether dates represent baseline or endline
- Follow-up horizon (months post-program)
- Whether `treatstat` = assignment or receipt, and planned IV correction
- Pre-analysis plan / pre-registration
- Subgroup analysis plan for gender/SES (sample sizes for heterogeneity)

---

### Composite Score

| Dimension | Score | Weight | Weighted |
|-----------|-------|--------|---------|
| Research Question | 8 | 0.15 | 1.20 |
| Identification | 8 | 0.30 | 2.40 |
| Data Feasibility | 4 | 0.20 | 0.80 |
| Novelty | 7 | 0.15 | 1.05 |
| Impact | 8 | 0.10 | 0.80 |
| Threats Addressed | 6 | 0.10 | 0.60 |
| **Composite** | | | **6.85** |

---

```json
{
  "question_score": 8,
  "identification_score": 8,
  "data_score": 4,
  "novelty_score": 7,
  "impact_score": 8,
  "threats_addressed_score": 6,
  "composite_score": 6.85,
  "top_threats": [
    "underpowered interaction test (no power analysis for beta_3)",
    "date range implies baseline/pre-treatment data, not post-program follow-up",
    "multiple undefined outcome variables with no primary outcome pre-specified"
  ],
  "verdict": "NEEDS_WORK",
  "one_line_summary": "Conceptually strong factorial RCT design with clean identification, fatally undermined by missing power analysis for the interaction term and strong evidence the available data may be pre-treatment baseline rather than post-program follow-up."
}
```

---

---

## META-REVIEW

**Reviewing the evaluation above for fairness, consistency, completeness, and constructiveness.**

**Fairness:** The evaluation gives appropriate credit for the genuine strength of the identification strategy — a Tier 1 RCT — without inflating it due to unresolved compliance concerns. The data score of 4/10 is aggressive but defensible: the one-week date range is a legitimate red flag that the evaluator correctly identifies as potentially fatal. The novelty and impact scores (7, 8) are reasonable and not inflated.

**Consistency:** The narrative and scores align. Identification is praised and scored 8; data is criticized specifically and scored 4; threats drive the threats_addressed score down to 6. The composite score of 6.85 reflects the verdict "NEEDS_WORK" correctly — the design is sound but execution evidence is missing. No inconsistencies detected.

**Completeness:** The evaluation captures the most important issues. One potentially missed point: the proposal's claim that "β₃ is fully identified by randomization, requiring no additional assumptions" is slightly overconfident — SUTVA is itself an assumption, and in a labor market context it is non-trivial. The evaluator does flag SUTVA as a medium threat, so it is addressed, though the counter-claim in the proposal could have been directly challenged more sharply. A minor omission: the evaluator does not flag that pooled cross-sections (as opposed to panel) means the researcher cannot control for individual fixed effects, which, while not essential for an RCT, limits the precision of estimates and forecloses robustness checks.

**Constructiveness:** The feedback is actionable. The researcher knows exactly what to provide: a power calculation for β₃, clarification of the follow-up horizon, outcome variable definitions, and a compliance analysis plan. The verdict "NEEDS_WORK" rather than "WEAK" correctly signals that the underlying idea is worth pursuing.

**Overall assessment:** The evaluation is rigorous, internally consistent, appropriately calibrated, and gives the researcher a clear path to revision. No score changes are warranted.

**AGREE**